August 4, 2026
Most coverage of cannabis category sales in 2026 is about what is growing. The more useful list for anyone selling into dispensaries is the other one. In the twelve months ending June 2026, capsules fell 24.6%, topicals fell 13.8%, concentrates fell 7.7%, and tinctures fell 5.6% (Headset).
Those declines are happening in a market that grew, barely. Total US sales reached $24.3 billion across 16 tracked states, up 0.8%, while unit sales rose 5.5% to 1.42 billion items. People are buying more things for less money, and buyers are deciding which things stay on the shelf.
| Category | Sales | YoY | |---|---|---| | Flower | $9.60B | -0.7% | | Vapor pens | $6.15B | +0.8% | | Pre-rolls | $3.84B | +10.1% | | Edibles | $2.91B | +0.3% | | Concentrates | $1.23B | -7.7% | | Beverages | $289M | +7.8% | | Tinctures | $121M | -5.6% | | Capsules | $113M | -24.6% | | Topicals | $87M | -13.8% |
Source: Headset, 12 months ending June 2026.
Two things stand out. The growth is concentrated in pre-rolls and beverages, which we have covered as separate shelf events. And the four shrinking categories at the bottom now total under $1.6 billion combined, less than pre-rolls alone.
Capsules and topicals were always small categories. Concentrates weren't. A $1.23 billion category losing 7.7% in a year is a structural change, not a rounding error, and it is happening while vapor pens hold flat at $6.15 billion.
The likeliest explanation is substitution rather than abandonment. Dabbing requires equipment and ritual; a vape cart and an infused pre-roll deliver comparable potency with no setup. Infused pre-rolls are, functionally, concentrate sold in a format that needs no hardware, and that category is growing faster than anything else on the board. The extract is still selling. The jar is not.
Category share is only half the story. Across tracked US markets, the average discount rate rose from 22.8% in June 2025 to 26.0% in June 2026. More than a quarter of shelf value is now handed back at the register. Packaged flower prices fell 5.7% per gram, and the average product price landed at $15.91.
That is the pressure behind every assortment decision a buyer makes this year. When a quarter of gross is going to promotions, a SKU that turns slowly stops being a diversification play and starts being a cost. Slow categories get cut first because they are the easiest thing to cut.
If you supply a shrinking category, your accounts are reviewing you. A 24.6% decline in capsules means buyers who carried three brands are carrying one. The conversation to have now is about turns and margin per facing, not features.
If you supply packaging, hardware, or services, the shelf is rotating rather than emptying. Concentrate jars and droppers lose volume while pre-roll tubes, beverage cans, and vape components gain it. The same store is buying, just buying different things.
If you sell efficiency, this is your market. Discount rates near 26% and flat dollar growth on rising units describe operators whose margin problem is now permanent. POS analytics, inventory tools, payment processing, and anything that reduces shrink or labor cost all sell better in a compression year than in a growth year.
Timing matters more than usual this year. Assortment reviews are when facings change hands. A buyer resetting a planogram after a bad concentrate quarter is a buyer taking meetings, and that window closes once the new set is locked.
Which cannabis categories are declining in 2026? Capsules (-24.6%), topicals (-13.8%), concentrates (-7.7%), and tinctures (-5.6%) all lost ground in the twelve months ending June 2026, while pre-rolls (+10.1%) and beverages (+7.8%) grew.
Is the cannabis market shrinking overall? No. US sales across 16 tracked states rose 0.8% to $24.3 billion, and units rose 5.5%. Prices are what's falling, not demand.
Why are concentrate sales dropping? The data shows the decline, not the cause. The most likely driver is substitution toward vapor pens and infused pre-rolls, which deliver similar potency without hardware.
Shelf resets happen store by store, and the decision-maker is rarely the person at the counter. See verified, owner-level dispensary contacts across six states. Free preview here.
Holden Leads
Holden Leads tracks every licensed dispensary across California, Michigan, Illinois, Massachusetts, New York, Colorado, Oregon, Washington, Nevada, and Maine — cross-referenced weekly against official state regulatory databases and enriched with phone numbers, emails, websites, and social profiles. Stop manually hunting for contact info. Get the full list today.